Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Detection of human leptospirosis as a cause of acute fever by capture ELISA using a Leptospira interrogansserovar Copenhageni (M20) derived antigen

Authors: Enrique Canal, Simon Pollett, Kristen Heitzinger, Michael Gregory, Matthew Kasper, Eric Halsey, Yocelinda Meza, Kalina Campos, Juan Perez, Rina Meza, Maruja Bernal, Alfredo Guillen, Tadeusz J Kochel, Benjamin Espinosa, Eric R Hall, Ryan C Maves

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Leptospirosis is a potentially lethal zoonosis mainly affecting low-resource tropical countries, including Peru and its neighbouring countries. Timely diagnosis of leptospirosis is critical but may be challenging in the regions where it is most prevalent. The serodiagnostic gold standard microagglutination test (MAT) may be technically prohibitive. Our objective in this study was to assess the sensitivity, specificity, and predictive value of an IgM antibody capture enzyme-linked immunoassay (MAC-ELISA) derived from the M20 strain of Leptospira interrogans serovar Copenhageni (M20) by comparison to MAT, which was used as the gold standard method of diagnosis.

Methods

Acute and convalescent sera from participants participating in a passive febrile surveillance study in multiple regions of Peru were tested by both IgM MAC-ELISA and MAT. The sensitivity, specificity, positive and negative predictive value (PPV, NPV) of the MAC-ELISA assay for acute, convalescent and paired sera by comparison to MAT were calculated.

Results

The sensitivity, specificity, PPV and NPV of the MAC-ELISA assay for acute sera were 92.3%, 56.0%, 35.3% and 96.6% respectively. For convalescent sera, the sensitivity, specificity, PPV and NPV of the MAC-ELISA assay were 93.3%, 51.5%, 63.6% and 89.5% respectively. For paired sera, the sensitivity, specificity, PPV and NPV of the MAC-ELISA assay were 93.6%, 37.5%, 59.2%, 85.7% respectively.

Conclusions

The M20 MAC-ELISA assay performed with a high sensitivity and low specificity in the acute phase of illness. Sensitivity was similar as compared with MAT in the convalescent phase and specificity remained low. Paired sera were the most sensitive but least specific by comparison to MAT serodiagnosis. NPV for acute, convalescent and paired sera was high. The limited specificity and high sensitivity of the MAC-ELISA IgM suggests that it would be most valuable to exclude leptospirosis in low-resource regions that lack immediate access to definitive reference laboratory techniques such as MAT.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lau C, Smythe L, Weinstein P: Leptospirosis: an emerging disease in travellers. Travel Med Infect Dis. 2010, 8 (1): 33-39. 10.1016/j.tmaid.2009.12.002.CrossRefPubMed Lau C, Smythe L, Weinstein P: Leptospirosis: an emerging disease in travellers. Travel Med Infect Dis. 2010, 8 (1): 33-39. 10.1016/j.tmaid.2009.12.002.CrossRefPubMed
2.
go back to reference Levett PN: Leptospirosis. Clin Micro Review. 2001, 14 (2): 296-326. 10.1128/CMR.14.2.296-326.2001.CrossRef Levett PN: Leptospirosis. Clin Micro Review. 2001, 14 (2): 296-326. 10.1128/CMR.14.2.296-326.2001.CrossRef
3.
go back to reference Levett PN, Mandel GL, Mandell D: Mandell, Douglas & Bennett's Principles and Practice of Infectious Diseases. 2010, Philidelphia, PA: Elsevier Publishing Co, Chapter 216, 7 Levett PN, Mandel GL, Mandell D: Mandell, Douglas & Bennett's Principles and Practice of Infectious Diseases. 2010, Philidelphia, PA: Elsevier Publishing Co, Chapter 216, 7
4.
go back to reference Bharti AR, et al: Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003, 3 (12): 757-771. 10.1016/S1473-3099(03)00830-2.CrossRefPubMed Bharti AR, et al: Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003, 3 (12): 757-771. 10.1016/S1473-3099(03)00830-2.CrossRefPubMed
5.
go back to reference Toyokawa T, Ohnishi M, Koizumi N: Diagnosis of acute leptospirosis. Expert Rev Anti Infect Ther. 2011, 9 (1): 111-121. 10.1586/eri.10.151.CrossRefPubMed Toyokawa T, Ohnishi M, Koizumi N: Diagnosis of acute leptospirosis. Expert Rev Anti Infect Ther. 2011, 9 (1): 111-121. 10.1586/eri.10.151.CrossRefPubMed
6.
go back to reference Vinetz JM: Ten Common Questions About Leptospirosis. Infect Dis Clin Pract. 2000, 9 (2): 59-65. 10.1097/00019048-200009020-00006.CrossRef Vinetz JM: Ten Common Questions About Leptospirosis. Infect Dis Clin Pract. 2000, 9 (2): 59-65. 10.1097/00019048-200009020-00006.CrossRef
7.
8.
go back to reference Russell KL, et al: An outbreak of leptospirosis among Peruvian military recruits. Am J Trop Med Hyg. 2003, 69 (1): 53-57.PubMed Russell KL, et al: An outbreak of leptospirosis among Peruvian military recruits. Am J Trop Med Hyg. 2003, 69 (1): 53-57.PubMed
9.
go back to reference Wright H, Goot K, Rogers B: Spirochaetes and sunshine: leptospirosis in the aftermath of the Queensland floods. Med J Aust. 2012, 196 (8): 500-502.CrossRefPubMed Wright H, Goot K, Rogers B: Spirochaetes and sunshine: leptospirosis in the aftermath of the Queensland floods. Med J Aust. 2012, 196 (8): 500-502.CrossRefPubMed
10.
go back to reference Levett PN, et al: Detection of pathogenic leptospires by real-time quantitative PCR. J Med Microbiol. 2005, 54 (Pt 1): 45-49.CrossRefPubMed Levett PN, et al: Detection of pathogenic leptospires by real-time quantitative PCR. J Med Microbiol. 2005, 54 (Pt 1): 45-49.CrossRefPubMed
11.
go back to reference Cumberland P, Everard CO, Levett PN: Assessment of the efficacy of an IgM-elisa and microscopic agglutination test (MAT) in the diagnosis of acute leptospirosis. Am J Trop Med Hyg. 1999, 61 (5): 731-734.PubMed Cumberland P, Everard CO, Levett PN: Assessment of the efficacy of an IgM-elisa and microscopic agglutination test (MAT) in the diagnosis of acute leptospirosis. Am J Trop Med Hyg. 1999, 61 (5): 731-734.PubMed
12.
go back to reference Levett PN, Branch SL: Evaluation of two enzyme-linked immunosorbent assay methods for detection of immunoglobulin M antibodies in acute leptospirosis. Am J Trop Med Hyg. 2002, 66 (6): 745-748.PubMed Levett PN, Branch SL: Evaluation of two enzyme-linked immunosorbent assay methods for detection of immunoglobulin M antibodies in acute leptospirosis. Am J Trop Med Hyg. 2002, 66 (6): 745-748.PubMed
13.
go back to reference Bajani MD, et al: Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol. 2003, 41 (2): 803-809. 10.1128/JCM.41.2.803-809.2003.CrossRefPubMedPubMedCentral Bajani MD, et al: Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol. 2003, 41 (2): 803-809. 10.1128/JCM.41.2.803-809.2003.CrossRefPubMedPubMedCentral
14.
go back to reference Chirathaworn C, et al: Comparison of a slide agglutination test, LeptoTek Dri-Dot, and IgM-ELISA with microscopic agglutination test for Leptospira antibody detection. Southeast Asian J Trop Med Public Health. 2007, 38 (6): 1111-1114.PubMed Chirathaworn C, et al: Comparison of a slide agglutination test, LeptoTek Dri-Dot, and IgM-ELISA with microscopic agglutination test for Leptospira antibody detection. Southeast Asian J Trop Med Public Health. 2007, 38 (6): 1111-1114.PubMed
15.
go back to reference Johnson MA, et al: Environmental exposure and leptospirosis. Peru. Emerg Infect Dis. 2004, 10 (6): 1016-1022. 10.3201/eid1006.030660.CrossRefPubMed Johnson MA, et al: Environmental exposure and leptospirosis. Peru. Emerg Infect Dis. 2004, 10 (6): 1016-1022. 10.3201/eid1006.030660.CrossRefPubMed
16.
go back to reference Forshey BM, et al: Arboviral etiologies of acute febrile illnesses in Western South America, 2000–2007. PLoS Negl Trop Dis. 2010, 4 (8): e787-10.1371/journal.pntd.0000787.CrossRefPubMedPubMedCentral Forshey BM, et al: Arboviral etiologies of acute febrile illnesses in Western South America, 2000–2007. PLoS Negl Trop Dis. 2010, 4 (8): e787-10.1371/journal.pntd.0000787.CrossRefPubMedPubMedCentral
17.
go back to reference Roshanravan B, et al: Endemic malaria in the Peruvian Amazon region of Iquitos. Am J Trop Med Hyg. 2003, 69 (1): 45-52.PubMed Roshanravan B, et al: Endemic malaria in the Peruvian Amazon region of Iquitos. Am J Trop Med Hyg. 2003, 69 (1): 45-52.PubMed
18.
go back to reference Santana Vdos S, et al: Concurrent Dengue and malaria in the Amazon region. Rev Soc Bras Med Trop. 2010, 43 (5): 508-511. 10.1590/S0037-86822010000500007.CrossRefPubMed Santana Vdos S, et al: Concurrent Dengue and malaria in the Amazon region. Rev Soc Bras Med Trop. 2010, 43 (5): 508-511. 10.1590/S0037-86822010000500007.CrossRefPubMed
19.
go back to reference Manock SR, et al: Etiology of acute undifferentiated febrile illness in the Amazon basin of Ecuador. Am J Trop Med Hyg. 2009, 81 (1): 146-151.PubMed Manock SR, et al: Etiology of acute undifferentiated febrile illness in the Amazon basin of Ecuador. Am J Trop Med Hyg. 2009, 81 (1): 146-151.PubMed
20.
go back to reference Ganoza CA, et al: Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med. 2006, 3 (8): e308-10.1371/journal.pmed.0030308.CrossRefPubMedPubMedCentral Ganoza CA, et al: Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med. 2006, 3 (8): e308-10.1371/journal.pmed.0030308.CrossRefPubMedPubMedCentral
21.
go back to reference Norman AF, et al: Differentiation of Bartonella-like isolates at the species level by PCR-restriction fragment length polymorphism in the citrate synthase gene. J Clin Microbiol. 1995, 33 (7): 1797-1803.PubMedPubMedCentral Norman AF, et al: Differentiation of Bartonella-like isolates at the species level by PCR-restriction fragment length polymorphism in the citrate synthase gene. J Clin Microbiol. 1995, 33 (7): 1797-1803.PubMedPubMedCentral
22.
go back to reference Cole JR, Sulzer CR, Pursell AR: Improved microtechnique for the leptospiral microscopic agglutination test. Appl Microbiol. 1973, 25 (6): 976-980.PubMedPubMedCentral Cole JR, Sulzer CR, Pursell AR: Improved microtechnique for the leptospiral microscopic agglutination test. Appl Microbiol. 1973, 25 (6): 976-980.PubMedPubMedCentral
23.
go back to reference Stern EJ, et al: Outbreak of leptospirosis among Adventure Race participants in Florida, 2005. Clin Infect Dis. 2010, 50 (6): 843-849. 10.1086/650578.CrossRefPubMed Stern EJ, et al: Outbreak of leptospirosis among Adventure Race participants in Florida, 2005. Clin Infect Dis. 2010, 50 (6): 843-849. 10.1086/650578.CrossRefPubMed
24.
go back to reference World Health Organisation: Human leptospirosis: guidance for diagnosis, surveillance and control. 2003, Geneva, Switzerland: WHO World Health Organisation: Human leptospirosis: guidance for diagnosis, surveillance and control. 2003, Geneva, Switzerland: WHO
25.
go back to reference Blanco RM, Takei K, Romero EC: Leptospiral glycolipoprotein as a candidate antigen for serodiagnosis of human leptospirosis. Lett Appl Microbiol. 2009, 49 (2): 267-273. 10.1111/j.1472-765X.2009.02650.x.CrossRefPubMed Blanco RM, Takei K, Romero EC: Leptospiral glycolipoprotein as a candidate antigen for serodiagnosis of human leptospirosis. Lett Appl Microbiol. 2009, 49 (2): 267-273. 10.1111/j.1472-765X.2009.02650.x.CrossRefPubMed
26.
go back to reference Pinne M, Haake DA: A comprehensive approach to identification of surface-exposed, outer membrane-spanning proteins of Leptospira interrogans. PLoS One. 2009, 4 (6): e6071-10.1371/journal.pone.0006071.CrossRefPubMedPubMedCentral Pinne M, Haake DA: A comprehensive approach to identification of surface-exposed, outer membrane-spanning proteins of Leptospira interrogans. PLoS One. 2009, 4 (6): e6071-10.1371/journal.pone.0006071.CrossRefPubMedPubMedCentral
27.
go back to reference Thongboonkerd V: Proteomics in leptospirosis research: towards molecular diagnostics and vaccine development. Expert Rev Mol Diagn. 2008, 8 (1): 53-61. 10.1586/14737159.8.1.53.CrossRefPubMed Thongboonkerd V: Proteomics in leptospirosis research: towards molecular diagnostics and vaccine development. Expert Rev Mol Diagn. 2008, 8 (1): 53-61. 10.1586/14737159.8.1.53.CrossRefPubMed
28.
go back to reference Felgner P: American Society of Tropical Medicine and Hygiene. Serodiagnostic antigen discovery for leptospirosis disease (Scientific Oral Presentation). 2011, Philadelphia Felgner P: American Society of Tropical Medicine and Hygiene. Serodiagnostic antigen discovery for leptospirosis disease (Scientific Oral Presentation). 2011, Philadelphia
Metadata
Title
Detection of human leptospirosis as a cause of acute fever by capture ELISA using a Leptospira interrogansserovar Copenhageni (M20) derived antigen
Authors
Enrique Canal
Simon Pollett
Kristen Heitzinger
Michael Gregory
Matthew Kasper
Eric Halsey
Yocelinda Meza
Kalina Campos
Juan Perez
Rina Meza
Maruja Bernal
Alfredo Guillen
Tadeusz J Kochel
Benjamin Espinosa
Eric R Hall
Ryan C Maves
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-438

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine